Agilus Diagnostics launches comprehensive obesity, metabolic health test suite
The growing burden of obesity underscores the need for comprehensive diagnostics that support prevention, guide clinical decision making, and monitor long term metabolic risks
With one of the world’s largest populations at risk for diabetes, cardiovascular disease, and fatty liver, India stands to benefit significantly from standardised diagnostic protocols.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Advertisement
Agilus Diagnostics, a subsidiary of Fortis Healthcare Ltd, today announced the launch of the Complete Care Vital Shape test suite (Lite, Core, and Ultra). This structured portfolio is designed for smarter weight management, early detection of insulin resistance, and long-term metabolic health monitoring — especially relevant amid rising global attention on GLP-1-based therapies for obesity.
India continues to witness a steep rise in obesity, with nearly one in four females and two in five males now overweight or obese. In urban populations, prevalence has reached 30-40 per cent, driven by lifestyle and dietary changes.
Advertisement
In a press release, Dr Anand K, managing director & CEO, Agilus Diagnostics, said: “We are witnessing a global shift in obesity care, especially with the increasing use of GLP-1-based therapies. As clinical practices evolve, diagnostics must evolve with them. Complete Care Vital Shape empowers clinicians with comprehensive insights into insulin resistance, fatty liver, metabolic syndrome and cardiometabolic disorders.”
Advertisement
Advertisement